Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis

Abstract

One-year tofacitinib treatment stabilized BMD in RA patients and resulted in a positive balance of bone turnover as indicated by bone biomarkers. Further studies are needed to evaluate the potential beneficial effects of JAK inhibitors on inflammatory bone loss.